What are the diagnostic criteria for polycystic ovaries (PCOS) on ultrasound in a female patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ultrasound Diagnostic Criteria for Polycystic Ovaries

The gold standard ultrasound criterion for diagnosing polycystic ovarian morphology is ≥20 follicles per ovary (measuring 2-9mm in diameter), which demonstrates 87.64% sensitivity and 93.74% specificity. 1

Primary Diagnostic Thresholds

Follicle Number Per Ovary (FNPO) is the most accurate ultrasonographic marker and should be prioritized when technically feasible. 1

  • ≥20 follicles per ovary (2-9mm diameter) is the recommended threshold, with superior diagnostic accuracy (AUC 0.905) compared to other markers 1
  • This threshold is substantially higher than the older Rotterdam 2003 criterion of ≥12 follicles, which has been shown to result in overdiagnosis due to high false-positive rates in healthy women 2, 3
  • FNPO demonstrates less within-study and between-study variability compared to alternative markers 1

Alternative Diagnostic Markers

When accurate follicle counting is not possible due to technical limitations or image quality, use these alternatives in order of preference: 1

Ovarian Volume (OV):

  • >10 mL (10 cm³) threshold serves as a robust alternative 1, 4
  • Demonstrates 81.48% sensitivity and 81.04% specificity in adults 1
  • Lower diagnostic accuracy (AUC 0.856) compared to FNPO but remains clinically useful 1

Follicle Number Per Single Cross-Section (FNPS):

  • ≥9 follicles in a single cross-section provides intermediate diagnostic accuracy 2
  • Shows 81.07% sensitivity and 82.70% specificity 1
  • Can be used when counting throughout the entire ovary is unavailable 1

Technical Requirements for Optimal Imaging

Transvaginal ultrasound with ≥8 MHz transducer frequency is mandatory for optimal resolution in adults. 1, 5

  • Higher transducer frequency (≥8 MHz) significantly improves diagnostic accuracy compared to <8 MHz 1
  • Studies using ≥8 MHz transducers show diagnostic odds ratio of 106.83 versus 34.09 for FNPO 1
  • Document three dimensions and calculate volume of each ovary 6
  • Ensure no corpora lutea, cysts, or dominant follicles ≥10mm are present, as these invalidate the assessment 6

Age-Specific Considerations

Critical Pitfall: Ultrasound should NOT be used as a first-line diagnostic tool in adolescents. 1, 5

  • Avoid ultrasound in patients <8 years post-menarche or <20 years old due to poor specificity (high false-positive rates from normal multifollicular ovaries) 1, 5, 6
  • In adolescents, rely primarily on clinical and biochemical hyperandrogenism plus menstrual irregularity persisting 2-3 years beyond menarche 5
  • If ultrasound is performed in adolescents, ovarian volume shows 81.84% sensitivity and 83.54% specificity, but interpretation requires extreme caution 1

Diagnostic Algorithm

Step 1: Use transvaginal ultrasound with ≥8 MHz transducer in adults (≥18 years, >8 years post-menarche) 1, 5

Step 2: Count total follicles (2-9mm) throughout the entire ovary using systematic scanning 1, 2

  • If FNPO ≥20 in either ovary → Polycystic ovarian morphology confirmed 1, 5

Step 3: If accurate follicle counting is impossible, measure ovarian volume 1, 6

  • If OV >10 mL in either ovary → Polycystic ovarian morphology confirmed 1, 5

Step 4: If neither FNPO nor OV can be reliably assessed, use FNPS 1

  • If ≥9 follicles in single cross-section → Suggests polycystic ovarian morphology 2

Critical Clinical Pitfalls to Avoid

Polycystic ovarian morphology alone does NOT diagnose PCOS. 5, 6

  • Up to one-third of reproductive-aged women without PCOS have polycystic ovarian morphology on ultrasound 5
  • PCOS diagnosis requires at least 2 of 3 Rotterdam criteria: oligo/anovulation, clinical/biochemical hyperandrogenism, and polycystic ovarian morphology 5, 4
  • Other conditions must be excluded (thyroid disease, hyperprolactinemia, Cushing's syndrome, androgen-secreting tumors, congenital adrenal hyperplasia) 5, 7

Do not use the outdated ≥12 follicle threshold from 2003 Rotterdam criteria. 2, 3

  • This lower threshold results in overdiagnosis with poor specificity 2, 3
  • Recent meta-analysis confirms ≥20 follicles provides optimal balance of sensitivity and specificity 1

Presence of an IUD does not interfere with ovarian imaging. 6

  • The IUD sits within the endometrial cavity while ovaries are separate lateral pelvic structures 6
  • Acoustic shadowing from the IUD does not extend to the ovaries 6

Geographic and Diagnostic Criteria Variations

Diagnostic accuracy varies by PCOS diagnostic criteria used: 1

  • Rotterdam criteria show higher sensitivity (89.81%) but slightly lower specificity (89.79%) for FNPO 1
  • NIH 1990 criteria show lower sensitivity (81.76%) but higher specificity (91.06%) for FNPO 1
  • Asian studies preferentially use Rotterdam criteria (71% of studies), while North American studies exclusively use NIH criteria (100% of studies) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Polycystic ovary syndrome (PCOS).

Annales d'endocrinologie, 2010

Guideline

Diagnostic Criteria and Treatment Options for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ultrasound Visualization of PCOS in Patients with an IUD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Evaluations for Suspected Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.